Firms ally to develop drugs for rare genetic disorders

Nimbus Discovery and Shire agreed to collaborate in the discovery and development of small molecule drugs for lysosomal storage disorders using the former's computational chemistry platform. Nimbus will be in charge of discovery, and Shire will handle clinical development and commercialization. The deal entitles Nimbus to undisclosed milestone payments.

View Full Article in:

Genetic Engineering & Biotechnology News · Boston Herald

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI